drugset / Trial / NCT00322257
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in the United States of America (USA) and Canada. The aim of this research is to compare the efficacy (reduction in HbA1c and blood glucose) and pulmonary safety (pulmonary function, chest x-rays) of mealtime inhaled insulin with subcutaneous insulin aspart both in combination with insulin determir in Type 1 Diabetes.
Timeline
- Start
- 2006-05-01
- Primary completion
- 2008-04-02
- Completion
- 2008-04-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Inhaled |
| Comparator | insulin aspart | Protein / enzyme biologic | — | Subcutaneous |
| Background | insulin detemir | Protein / enzyme biologic | 50 % | Subcutaneous |